Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the ability of Vascana (0.9% nitroglycerin topical
cream) to treat and prevent the symptoms experienced by subject's with Raynaud's Phenomenon.
The symptoms of this disease include pain, tingling, and numbness in the fingers of the
affected hand or hands.